Richards Group (RIC) Q3 2025 earnings summary

Executive summary

• Shifted focus from acquisitions to integration and internal reorganization, including a proposed conversion from an income trust to a corporation effective December 2025.

• Challenging demand environment in the US impacted food & beverage packaging, while healthcare and cosmetics segments showed resilience.

• Ecommerce channel launched in late summer, with early signs of margin improvement as its share grows.

• Three acquisitions completed: DermapenWorld, National Dental Inc., and HL Production SA, contributing to revenue growth.

Financial highlights

• Q3 revenue increased 11.1% year-over-year to $108.5 million, driven by acquisitions and healthcare growth.

• Net income for the nine months was $13.7 million, down from $27.2 million year-over-year, impacted by $5.9 million in exceptional items and higher fixed costs.

• Adjusted EBITDA for the nine months was $40.0 million (12.5% of sales), down from $41.6 million (13.7%).

• Gross margin for Q3 was 19.2%, slightly down from 19.7% in the prior year.

• Distributable cash flow for the nine months was $24.5 million, with a payout ratio of 46%.

Outlook and guidance

• Management expects to sustain monthly distributions at current levels through 2025.

• Healthcare growth (excluding acquisitions) expected to be flat in Q4, with ecommerce launches anticipated to drive additional growth.

• Administrative expenses and lease payments expected to rise in Q4 due to acquisitions.